Daniel Abdun-Nabi

Insider Reports History

Location
Seattle, WA
Signature
/s/ SoYoung Kwon, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel Abdun-Nabi:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aptevo Therapeutics Inc. Director Common Stock 1 $0 $0.3400 17 Jul 2025 Direct
REGENXBIO Inc. Director Stock Option (Right to Buy) 10,000 04 Jun 2021 Direct
Aptevo Therapeutics Inc. Director Restricted Stock Unit 7,200 06 Aug 2025 Direct

Insider Reports Filed by Daniel Abdun-Nabi

Symbol Company Period Transactions Value $ Form Type Role Filing Time
APVO Aptevo Therapeutics Inc. 06 Aug 2025 1 $0 4 Director 08 Aug 2025, 16:36
APVO Aptevo Therapeutics Inc. 17 Jul 2025 2 $0 4 Director 21 Jul 2025, 16:41
APVO Aptevo Therapeutics Inc. 17 Jul 2024 1 $0 4 Director 19 Jul 2024, 16:30
APVO Aptevo Therapeutics Inc. 01 Jun 2024 4 $0 4 Director 03 Jun 2024, 16:58
APVO Aptevo Therapeutics Inc. 09 Aug 2023 2 $0 4 Director 10 Aug 2023, 16:05
APVO Aptevo Therapeutics Inc. 01 Jun 2023 3 $0 4 Director 02 Jun 2023, 16:43
APVO Aptevo Therapeutics Inc. 09 Aug 2022 1 $0 4 Director 10 Aug 2022, 16:09
APVO Aptevo Therapeutics Inc. 01 Jun 2022 2 $0 4 Director 03 Jun 2022, 15:16
RGNX REGENXBIO Inc. 04 Jun 2021 1 $0 4 Director 08 Jun 2021, 16:13
APVO Aptevo Therapeutics Inc. 01 Jun 2021 2 $0 4 Director 02 Jun 2021, 19:32
APVO Aptevo Therapeutics Inc. 03 Aug 2016 0 $0 4/A Director 07 Mar 2023, 15:38